首页> 美国卫生研究院文献>MedChemComm >Inhibition of O-GlcNAc transferase (OGT) by peptidic hybrids
【2h】

Inhibition of O-GlcNAc transferase (OGT) by peptidic hybrids

机译:肽杂种对O-GlcNAc转移酶(OGT)的抑制作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

O-GlcNAc transferase (OGT) attaches a GlcNAc moiety on specific substrate proteins using UDP-GlcNAc as the sugar donor. This modification can alter protein function by regulating cellular signaling and transcription pathways in response to altered nutrient availability and stress. Specific inhibitors of OGT would be valuable tools for biological studies and lead structures for therapeutics. The existing OGT inhibitors are mainly derived from the sugar donor substrate, but poor cell permeability and off-target effects limit their use. Here, we describe our progress on OGT inhibition based on substrate peptides identified by array screening. Subsequently, bisubstrate inhibitors were prepared by conjugating these peptides to uridine in various ways. In parallel, an in silico fragment screening was conducted to obtain small molecules targeting the UDP binding pocket. After evaluation of the initial hits, one of these small molecules was elaborated into a novel OGT hybrid inhibitor, as the replacement of uridine. The novel compounds inhibit OGT activity with IC50 values in the micromolar range.
机译:O-GlcNAc转移酶(OGT)使用UDP-GlcNAc作为糖供体将GlcNAc部分连接到特定的底物蛋白上。这种修饰可以通过调节细胞信号传导和转录途径来改变蛋白质的功能,以响应营养物利用率和压力的变化。 OGT的特定抑制剂将是生物学研究和治疗药物的先导结构的有价值的工具。现有的OGT抑制剂主要来自糖供体底物,但细胞通透性差和脱靶效应限制了它们的使用。在这里,我们描述了基于阵列筛选鉴定的底物肽对OGT抑制的进展。随后,通过以各种方式将这些肽与尿苷缀合来制备双底物抑制剂。并行地,进行计算机片段筛选以获得靶向UDP结合口袋的小分子。在评估初始命中后,将这些小分子之一加工成新型OGT杂合抑制剂,作为尿苷的替代物。新化合物以微摩尔范围的IC50值抑制OGT活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号